ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Operating income 2015–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) annual operating income history from SEC filings — each fiscal year as reported.
-$68.8MFY2024 · since FY2015: -$24.6M → -$68.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$68.8M | +50.8% |
| FY2023 | -$139.7M | +14.8% |
| FY2022 | -$164.0M | -1.1% |
| FY2021 | -$162.2M | -21.6% |
| FY2020 | -$133.4M | +4.6% |
| FY2019 | -$139.8M | -69.7% |
| FY2018 | -$82.4M | -2.1% |
| FY2017 | -$80.7M | -10.8% |
| FY2016 | -$72.8M | -195.4% |
| FY2015 | -$24.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice